2024. CRISPR/Cas9-Mediated Reprogramming of Medicinal Plants for Enhanced Anti-Cancer Bioactive Compounds “Advances in Genome Editing for Plant-Derived Therapeutics”. Journal of Carcinogenesis. 23, 1 (Oct. 2024), 733–739. DOI:https://doi.org/10.64149/J.Carcinog.24.3.350-356.